Impact of COVID-19 on health service utilisation in sub-Saharan Africa: protocol for a scoping review

Tannor, Elliot Koranteng; Quentin, Wilm; Busse, Reinhard; Opoku, Daniel; Amuasi, John

doi:10.1136/bmjopen-2023-074769

Cited by 2 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols extension for Scoping Reviews (PRISMA-ScR) checklist for reporting our ndings [25,26]. The study design and protocol has been published [27].…”

Section: Methodsmentioning

confidence: 99%

The impact of COVID-19 on health service utilization in sub-Saharan Africa – a scoping review

Tannor,

Quentin,

Busse

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

Introduction The Coronavirus Disease 2019(COVID-19) pandemic has undoubtedly exposed weaknesses in health systems, especially in sub-Saharan Africa (SSA). Despite comparatively low rates of COVID-19 admissions and recorded deaths in SSA, the pandemic still had a significant impact on health service utilization (HSU). The aim of this scoping review is to synthesize the available evidence on HSU in SSA during the COVID-19 pandemic focusing on changes in HSU generally and amongst particular patient groups studied. Methods The Scoping review was guided by the methodological framework for conducting scoping reviews developed by Arskey and O’Malley. We identified relevant studies through a search of PubMed(MEDLINE), Embase, Scopus and Web of Science. We then provided a general descriptive overview of the extracted data focusing on the types of studies, patient groups and change in HSU. Results We identified 262 studies reporting on HSU in 39 countries in SSA. The median study duration was 364.5[IQR:89 - 730] days. Studies were mainly quantitative 192(73.3%) and retrospective 117(44.7%). The majority were multiple centre studies 163(62.2%), hospital-based 205 (78.2%) and in urban settings 121(46.2%). Median number of participants was 8329[IQR:103-5848] involving 62.7% females. Communicable diseases were the most studied disease category in 92(35.1%) and mainly among out-patients 92(34.2%). Change in HSU was reported in 249(95.0%) of studies with 221(84.4%) of studies reporting a decrease in HSU. The median decrease in HSU was 35.6% [IQR: 19.0-55.8] and median increase was 16.2% [IQR: 9.1-31.9]. HSU was mostly reported among maternal and child health patients 58(22.1%) and people living with Human immunodeficiency virus 32(12.2%). The patient groups with the highest percentage decrease and increase in HSU were cardiovascular diseases 68.0%[IQR:16.7-71.1] and surgical cases 38.3%[IQR 24.0-52.5] respectively. Conclusion HSU was generally reduced during the COVID-19 pandemic among different patient groups in SSA.

show abstract

Section: Methodsmentioning

confidence: 99%

The impact of COVID-19 on health service utilization in sub-Saharan Africa – a scoping review

Tannor,

Quentin,

Busse

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

The impact of COVID-19 on health service utilization in sub-Saharan Africa—a scoping review

Tannor,

Amuasi,

Busse

et al. 2024

BMC Global Public Health

View full text Add to dashboard Cite

Background Despite comparatively low rates of COVID-19 admissions and recorded deaths in sub-Saharan Africa (SSA), the pandemic still had significant impact on health service utilization (HSU). The aim of this scoping review is to synthesize the available evidence of HSU in SSA during the pandemic, focusing on types of studies, changes in HSU compared with the pre-pandemic period, and changes among specific patient groups. Methods The scoping review was guided by the methodological framework for conducting scoping reviews developed by Arksey and O’Malley. We identified relevant studies through a search of PubMed (MEDLINE), Embase, Scopus, and Web of Science. We then provided a general descriptive overview of the extracted data focusing on the types of studies, patient groups, and change in HSU. Results We identified 262 studies reporting on HSU in 39 SSA countries. Studies were mainly quantitative (192; 73.3%), involving multiple centers (163; 62.2%), conducted in hospitals (205; 78.2%), and in urban settings (121; 46.2%). The median number of participants was 836.5 (IQR: 101.5–5897) involving 62.5% females. Most studies (92; 35.1%) focused on communicable diseases and mainly among outpatients (90; 34.2%). Maternal and child health studies formed the largest patient group (58; 22.1%) followed by people living with HIV (32; 12.2%). Change in HSU was reported in 249 (95.0%) studies with 221 (84.4%) studies reporting a decrease in HSU. The median decrease in HSU was 35.6% (IQR: 19.0–55.8) and median increase was 16.2% (IQR: 9.1–31.9). The patient group with the largest percentage decrease was cardiovascular diseases (68.0%; IQR: 16.7–71.1) and the lowest percentage decrease was in patients with infections (27.0%; IQR: 16.6–45.6). Conclusions A large body of literature is available on the effects of the pandemic on HSU in SSA. Most studies report decreases in HSU during the pandemic. However, patterns differ widely across disease categories, patient groups, and during different time periods of the pandemic.

show abstract

Impact of COVID-19 on health service utilisation in sub-Saharan Africa: protocol for a scoping review

Cited by 2 publications

References 42 publications

The impact of COVID-19 on health service utilization in sub-Saharan Africa – a scoping review

The impact of COVID-19 on health service utilization in sub-Saharan Africa – a scoping review

The impact of COVID-19 on health service utilization in sub-Saharan Africa—a scoping review

Contact Info

Product

Resources

About